ArticleFrontiers in oncology2026

Real-world treatment patterns and outcomes of chemo-immunotherapy with or without radiotherapy in extensive-stage small cell lung cancer: the durvalumab expanded access cohort.

Urska Janzic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.